Why is ANG Lifesciences falling/rising?

As of 24-Jun, ANG Lifesciences India Ltd is currently priced at 28.22, reflecting a slight increase of 0.12 or 0.43%. The stock has recently experienced a trend reversal, gaining after eight consecutive days of decline. However, it remains below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a persistent downward trend. The stock has underperformed significantly over various periods, with a year-to-date decline of 36.85% and a staggering 45.87% drop over the past year. The company is facing severe financial challenges, including operating losses, a high debt-to-EBITDA ratio of 5.83, and negative returns on equity, which contribute to its classification as a strong sell. Additionally, 44.88% of promoter shares are pledged, adding further downward pressure in a falling market.
In the broader market context, the stock's recent performance contrasts sharply with the benchmark, as it has declined by 5.11% over the past week while the Sensex has gained 0.58%. This consistent underperformance against the benchmark over the last three years, coupled with negative EBITDA and a reported loss for the last 12 consecutive quarters, highlights the company's weak long-term fundamental strength. The falling investor participation, evidenced by a 29.53% drop in delivery volume, further reflects a lack of confidence among investors, contributing to the stock's overall decline.